Table 2.
Distribution frequency of EZH2 genotypes in 552 controls and 576 oral cancer patients
Variable | Controls (N=552) n (%) | Patients (N=576) n (%) | OR (95% CI) | AOR (95% CI) |
---|---|---|---|---|
rs6950683 | ||||
TT | 264 (47.8%) | 308 (53.5%) | 1.00 | 1.00 |
TC | 220 (39.9%) | 221 (38.4%) | 0.861 (0.671-1.104) | 0.893 (0.622-1.280) |
CC | 68 (12.3%) | 47 (8.2%) | 0.592 (0.395-0.890)* | 0.492 (0.274-0.884)* |
TC+CC | 288 (52.2%) | 268 (46.5%) | 0.798 (0.631-1.008) | 0.790 (0.563-1.108) |
rs2302427 | ||||
CC | 346 (62.7%) | 356 (61.8%) | 1.00 | 1.00 |
CG | 171 (31.0%) | 200 (34.7%) | 1.137 (0.883-1.463) | 0.930 (0.646-1.405) |
GG | 35 (6.3%) | 20 (3.5%) | 0.555 (0.314-1.002) | 0.611 (0.265-1.405) |
CG+GG | 206 (37.3%) | 220 (38.2%) | 1.038 (0.816-1.321) | 0.883 (0.623-1.250) |
rs3757441 | ||||
TT | 271 (49.1%) | 312 (54.2%) | 1.00 | 1.00 |
TC | 223 (40.4%) | 221 (38.4%) | 0.861 (0.672-1.102) | 0.887 (0.620-1.269) |
CC | 58 (10.5%) | 43 (7.5%) | 0.644 (0.420-0.987)* | 0.524 (0.284-0.968)* |
TC+CC | 281 (50.9%) | 264 (45.8%) | 0.816 (0.646-1.031) | 0.804 (0.573-1.127) |
rs41277434 | ||||
AA | 517 (93.6%) | 540 (93.7%) | 1.00 | 1.00 |
AC | 34 (6.2%) | 35 (6.1%) | 0.986 (0.606-1.604) | 1.546 (0.784-3.048) |
CC | 1 (0.2%) | 1 (0.2%) | 0.957 (0.060-15.347) | 3.341 (0.157-70.898) |
AC+CC | 35 (6.4%) | 36 (6.3%) | 0.985 (0.609-1.592) | 1.590 (0.814-3.104) |
The odds ratios (ORs) and with their 95% confidence intervals (CIs) were estimated by logistic regression models. The adjusted odds ratios (AORs) with their 95% confidence intervals (CIs) were estimated by multiple logistic regression models after controlling for age, gender, betel nut chewing, tobacco and alcohol consumption.